Actos Causes Bladder Cancer: Litigation Update

Our office wrote several blogs highlighting the fact that Actos (pioglitazone) has been linked to bladder cancer. Those individuals who have used the drug for extended periods of time have an increased risk of developing bladder cancer.

Read more about how Actos causes bladder cancer.

A recent update on Actos litigations was published in the Jere Beasley Report. The article, The Actos Litigation Update, explains how the lawyers at the law office of Beasley Allen are pursuing claims of bladder cancer diagnosis as a result of taking Actos for type 2 diabetes treatments. Two lawyers, Andy Birchfield and Roger Smith, are involved in the Bellwether trials, one of which opened early February and the other is set for July.

Since the U.S. Food & Drug Administration (FDA) warned that Actos use for more than one year appears to double the risk of developing bladder cancer, there have been over 6,000 lawsuits filed involving the cancer allegations with three of those claims going to trial. There are currently 17 cases scheduled to go to trial in 2014, including two Bellweather cases that are mentioned earlier in this report, and in the full article in the Jere Beasley Report.

Bladder Cancer Symptoms

If you or your loved one has taken Actos in the past as treatment for type 2 diabetes, they may be at risk for bladder cancer. The drug, if taken for longer than one year, doubles the risk of bladder cancer.

Below you will find some symptoms of bladder cancer:

Urine that is red in color or contains blood
Increasing urge to urinate
Pain when urinating

Contacting a Lawyer

If you believe that you should speak to a lawyer about Actos, type 2 diabetes, and the risk of developing bladder cancer, feel free to call our office. We can help to explain things to you, answer the questions that you have related to Actos, and help you take the steps necessary toward justice. Call 800.637.8170 for answers today.

Charles E. Boyk Law Offices, LLC